# Home-based Remote Monitoring

Study · id `cardio:ct-nct05295303` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05295303](<https://clinicaltrials.gov/study/NCT05295303>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05295303

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 344 participants.

## Technical summary

Registry record NCT05295303. Randomized; no masking; primary purpose treatment. Start 2022-07-01 (anticipated); primary completion 2025-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 344 participants (planned count; ClinicalTrials.gov record NCT05295303, source copy `cardio:ctgov-nct05295303-2022-03-25`, retrieved 2026-10-26)
- Planned start: 2022-07-01 (anticipated) (ClinicalTrials.gov record NCT05295303, source copy `cardio:ctgov-nct05295303-2022-03-25`, retrieved 2026-10-26)
- Primary completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT05295303, source copy `cardio:ctgov-nct05295303-2022-03-25`, retrieved 2026-10-26)
- Completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT05295303, source copy `cardio:ctgov-nct05295303-2022-03-25`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT05295303, source copy `cardio:ctgov-nct05295303-2022-03-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05295303-2022-03-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Home-based Remote Monitoring
- Acronym: QIBO
- Condition: Myocardial Infarction
- Intervention (Device): Remote integrated post-MI management system
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

## Provenance

Content hash: 1d50d0a66795ad5e1a5d28d19a10509bcb74309d1f9493d4a688b5ad85a3dc91
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
